Reuters
10 Jul 2008
SINGAPORE, July 10 (Reuters) - Life-science companies with no financial track record may soon be allowed to list their shares on the Singapore Exchange (SGXL.SI: Quote, Profile, Research, Stock Buzz) as long as they demonstrate the ability to generate revenue and attract investors.
>>>> More
